Launch of [KIPRES Tablet], Leukotriene Receptor Antagonist/Bronchial Asthma Treatment Medicine in Japan
August 31, 2001
Kyorin Pharmaceutical Co., Ltd. (President: Ikuo Ogihara, Head Office: Tokyo) has launched the leukotriene receptor antagonist/ bronchial asthma treatment medicine Kipres Tablet 10 and Kipres Chewable Tablet 5 in Japan .
Recently, leukotriene (a chemical mediator), which is strongly related to inflammation of the bronchial airway, has been the focus of our attention. Merck & Co., Inc originally developed KIPRES tablets, which are leukotriene receptor antagonists that are selective to CysLT1.
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.